RSRafael Sanjuan

Rafael Sanjuan

*This is an algorithmically generated author record based on publicly available information.

Rafael Sanjuan has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Insulin resistance and short-term mortality in patients with acute myocardial infarction

    by Rafael Sanjuan, Maria L. Blasco, Rotzel Huerta, Lorena Palacios, Arturo Carratala, Julio Nunyez, Juan Sanchis


  • Low rate of detection of active cytomegalovirus (CMV) infection early following acute myocardial infarction

    by Julio Núñez, Marifina Chilet, Maria L. Blasco, María A. Clari, Rafael Sanjuan, Beatriz Muñoz-Cobo, Vicent Bodí, Elisa Costa, Dayana Bravo, Juan Sanchis, et al.


  • Repercusión ecocardiográfica del estado de hidratación en los pacientes en diálisis

    by Isabel Juan-García, María J Puchades, Rafael Sanjuán, Isidro Torregrosa, Miguel Á Solís, Miguel González, Marisa Blasco, Antonio Martínez, Alfonso Miguel

    Cardiovascular disease is the main cause of death in Chronic Kidney Disease patients. Left ventricular hypertrophy is the most common manifestation and it is linked to arterial hypertension and overhydration. The goal of this paper is to stratify dialyzed patients according to hydration status and to make an evaluation about the possible echocardiography alterations of the different groups. A transversal study was carried out with 117 patients: 65 were on hemodialysis and 52 on peritoneal dialysis. We performed the following tests: multifrequency bioimpedance with the BCM-Body Composition Freesenius’ Monitor system, transthoracic echocardiography, and blood tests. If ECW/TBW (extracellular water vs total body water) normalization ratio for age and gender was > 2.5% SD, the patient was considered overhydrated. HD patients are significantly overhydrated before HD (67.1%) compared to DP patients (46.1%), and almost half of the overhydrated population presents arterial hypertension. However, after an HD session, a better control of the hydration status is reached (26.1%). DP patients frequently present high arterial pressure and/or are under antihypertensive treatment (DP 76.9% vs HD 49.2%). Left ventricular hypertrophy is much more common in HD overhydrated patients, eccentric LVH being more prevalent. Overhydrated patients present significantly high values of LAVI, ILVM, OH/ECW. Bioimpedance technique allows for the detection of a large number of overhydrated patients. Echocardiographic alterations in dialyzed patients show a high correlation between the hydration stage by ECW/TBW normalized ratio for age and gender and the LAVI and ILVM.


  • Early biomarkers of acute kidney failure after heart angiography or heart surgery in patients with acute coronary syndrome or acute heart failure.

    by Isidro Torregrosa, Carmina Montoliu, Amparo Urios, Nisrin Elmlili, María Jesús Puchades, Miguel Angel Solís, Rafael Sanjuán, Maria Luisa Blasco, Carmen Ramos, Patricia Tomás, et al.

    Acute kidney injury (AKI) is a common complication in cardiac surgery and coronary angiography, which worsens patients' prognosis. The diagnosis is based on the increase in serum creatinine, which is delayed. It is necessary to identify and validate new biomarkers that allow for early and effective interventions. To assess the sensitivity and specificity of neutrophil gelatinase-associated lipocalin in urine (uNGAL), interleukin-18 (IL-18) in urine and cystatin C in serum for the early detection of AKI in patients with acute coronary syndrome or heart failure, and who underwent cardiac surgery or catheterization. The study included 135 patients admitted to the intensive care unit for acute coronary syndrome or heart failure due to coronary or valvular pathology and who underwent coronary angiography or cardiac bypass surgery or valvular replacement. The biomarkers were determined 12 hours after surgery and serum creatinine was monitored during the next six days for the diagnosis of AKI. The area under the ROC curve (AUC) for NGAL was 0.983, and for cystatin C and IL-18 the AUCs were 0.869 and 0.727, respectively. At a cut-off of 31.9 ng/ml for uNGAL the sensitivity was 100% and the specificity was 91%. uNGAL is an early marker of AKI in patients with acute coronary syndrome or heart failure and undergoing cardiac surgery and coronary angiography, with a higher predictive value than cystatin C or IL-18.


  • Plasma Brain Natriuretic Peptide Levels in Cardiac Function Assessment in Chronic Dialysis Patients

    by R. Sanjuan, S. Martín Oliva, M.L. Blasco, M. Puchades, I. Torregrosa, R. García Ramón, A. Miguel Carrasco

    Background: Brain natriuretic peptide (BNP) is elevated in patients with end-stage renal disease and could reflect left ventricular dysfunction. Aim: To evaluate the plasma levels of BNP in two groups of asymptomatic patients on different dialysis programs and to correlate their variations with echocardiographic parameters. Methods: Group A consisted of 36 patients on chronic hemodialysis (HD), and group B included 38 patients on continuous ambulatory peritoneal dialysis (CAPD). ECG and echocardiography were performed, and concomitantly plasma BNP levels were determined before and after a regular 4-hour session in HD patients and before performing a dialysate exchange in patients on CAPD. Results: BNP values in group A were found to be higher than in group B (419 ± 76 vs. 193 ± 56 pg/ml; p < 0.03). The cutoff point which discriminated both groups was 194 pg/ml (sensitivity: 64% and specificity: 76%; p = 0.001). Significant differences were found with respect to the following echocardiographic data (group A vs. group B): left atrial (LA) size (40 ± 13 vs. 34 ± 1 mm), LA volume (59 ± 16 vs. 41 ± 32 ml), transmitral flow E/A (1.17 ± 0.01 vs. 0.9 ± 0.06), the movement of the mitral valve annulus e/a (tissue Doppler imaging; 1.19 ± 0.15 vs. 1.05 ± 0.13) and left ventricular mass index (133 ± 10 vs. 108 ± 11). Conclusion: Patients on CAPD had lower levels of BNP, and echocardiographic findings indicated decreased volume overload. In asymptomatic patients, marked increases in BNP levels may reflect early stages of pathological processes that precede the development of apparent cardiac manifestations (left ventricular hypertrophy). Only echocardiographic parameters of cardiac dysfunction should be used as diagnostic criteria.


  • Estimated Glomerular Filtration Rate in Short-Risk Stratification in Acute Myocardial Infarction

    by Luisa Blasco, Rafael Sanjuan, Nieves Carbonell, Miguel A. Solís, María J. Puchades, Isidro Torregrosa, Juan A. Miguel

    Background/Aims: Renal dysfunction is associated with a higher risk of cardiovascular disease in patients with acute myocardial infarction (AMI). The aim of this study was to investigate the independent prognostic value of renal dysfunction and its incremental predictability risk after adjusting for well-known clinical factors in patients with AMI. Methods: 751 consecutive patients with AMI admitted to the Coronary Care Unit (CCU) were included. Patients were grouped into 2 categories according to the baseline estimated glomerular filtration rate (eGFR) on admission (eGFR 2). C-reactive protein and white blood cell count (WBC) as well as clinical prognostic variables were assessed. The endpoint was mortality during CCU stay. The discriminatory power was estimated by the C-index. Results: The patient group with an eGFR 2 was older, had more cardiovascular risk factors, a lower left ventricular ejection fraction and higher cardiovascular mortality during CCU stay (13 vs. 3%). Logistic regression analysis revealed the following predictors of mortality: degree of renal impairment (eGFR 11,000 × 106/l, HR = 2.3 (95% CI 1.2–4.5; p = 0.017); Killip class on admission, HR = 3.8 (95% CI 1.7–8.5; p = 0.001), and New York Heart Association Functional Classification, HR = 3.6 (95% CI 1.7–7.4; p = 0.001). The adjusted C-index was 0.78 for baseline clinical variables and 0.84 for eGFR. Conclusions: In patients with AMI, decreased eGFR is an important prognostic factor for impaired cardiac function and mortality in the short-term follow-up. The eGFR may be reliably used in the risk stratification of patients with AMI.


  • Implicaciones pronósticas de la hiperglucemia de estrés en el infarto agudo de miocardio con elevación del ST. Estudio observacional prospectivo

    by Rafael Sanjuán, Julio Núñez, M. Luisa Blasco, Gema Miñana, Helena Martínez-Maicas, Nieves Carbonell, Patricia Palau, Vicente Bodí, Juan Sanchis


  • Acute myocardial infarction: high risk ventricular tachyarrhythmias and admission glucose level in patients with and without diabetes mellitus.

    by Rafael Sanjuan, Maria L. Blasco, Helena Martinez-Maicas, Nieves Carbonell, Gema Minana, Julio Nunez, Vicente Bodi, Juan Sanchis

    Abstract: Objective: The aim of this study was to evaluate the impact of glucose levels on admission and High Risk Ventricular Tachyarrhythmia (HRVT) in hospital mortality in patients with Acute Myocardial Infarction (AMI). Methods: We studied 1.258 consecutive patients admitted to the Coronary Care Unit with a diagnosis of AMI. Ventricular Fibrillation, sustained and nonsustained Ventricular Tachycardia were considered as HRVT. Association between admission glucose, in-hospital mortality and HRVT was assessed with Cox regression analysis. Results: The overall incidence of in-hospital HRVT was 20% (254/1258 patients) and in-hospital mortality (115/1.258) was higher in patients with HRVT (20% vs. 6%) (p Multivariate risk adjusted hazard ratio (HR) analysis showed that, blood pressure 10.000 cell count (HR=1.44; 1.02-2)(p=0.04) and admission glycemia ≥180 mg/dL (HR=1.5; 1.04-2.3)( p=0.03) had a significantly increased risk in in-hospital HRTV only in NDM patients Conclusions: The higher glycemia on admission the higher prevalence of life-threatening arrhythmia and mortality regardless diabetes status in patients presenting with AMI. Elevated initial glucose level and WBC count considered along with other clinical data can assist in life-threatening ventricular arrhythmia in non diabetic patients.


  • Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery

    by Rafael Sanjuán, Marisa Blasco, Nieves Carbonell, Angela Jordá, Julio Núñez, Juan Martínez-León, Eduardo Otero